Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Nitrocefin: Chromogenic Cephalosporin Substrate for β-Lactam
2026-07-24
Nitrocefin empowers rapid, visual detection of β-lactamase activity, streamlining antibiotic resistance profiling and inhibitor screening. Its robust colorimetric change and compatibility with high-throughput workflows make it indispensable in both basic and translational research. Discover how to optimize Nitrocefin-based assays and troubleshoot common pitfalls for reproducible, sensitive results.
-
Nitrocefin Chromogenic Cephalosporin Substrate: Applied Prot
2026-07-24
Nitrocefin uniquely empowers rapid, quantifiable detection of β-lactamase activity, accelerating antibiotic resistance profiling and inhibitor screening. This guide distills evidence-driven workflows, troubleshooting insights, and the latest research advances—positioning Nitrocefin from APExBIO as the essential choice for robust, reproducible colorimetric β-lactamase assays.
-
CAY10499: Inhibitor of Human Hormone Sensitive Lipase in Lip
2026-07-23
CAY10499, a potent inhibitor of human hormone sensitive lipase, enables precise dissection of lipid-driven immunometabolic processes. Its nanomolar potency and selectivity empower researchers to unravel complex lipid signaling in tumor microenvironments and metabolic disease models.
-
GlycoRNA-RBP Nanoclusters Enable Cell Penetrating Peptide En
2026-07-23
The referenced study uncovers that RNA binding proteins (RBPs) and glycoRNAs form discrete nanoclusters on the cell surface, which act as entry points for cell penetrating peptides (CPPs) like TAT. This finding revises cell surface biology, highlighting new targets for mapping extracellular interactomes and improving delivery technologies.
-
Ferroptosis Inducers as a Novel Strategy for Advanced Prosta
2026-07-22
This study demonstrates that ferroptosis inducers, including Erastin, significantly impair growth and migration of treatment-resistant prostate cancer cells in vitro and delay tumor progression in vivo. The findings support the potential of ferroptosis-targeting compounds, alone or in combination with anti-androgens, as promising new therapeutic strategies for advanced prostate cancer.
-
Redefining Cre Recombinase mRNA Delivery for Extrahepatic Ed
2026-07-22
This thought-leadership article explores the evolution of Cre recombinase mRNA delivery, emphasizing the transformative potential of m1Ψ- and Cap 1-modified mRNAs—such as EZ Cap™ Cre mRNA (m1Ψ)—in overcoming extrahepatic targeting and immune activation barriers. Drawing on recent advances in virus-mimicking particle design, it provides strategic guidance for translational researchers aiming to achieve high-efficiency, low-immunogenicity gene editing across diverse tissues.
-
Firefly Luciferase mRNA: Enhanced Assays with 5-moUTP Modifi
2026-07-21
EZ Cap™ Firefly Luciferase mRNA (5-moUTP) delivers robust, immune-evasive bioluminescent reporter expression for gene regulation and translation efficiency studies. Its advanced 5-moUTP and Cap1 modifications translate into higher stability, superior protein yield, and reduced innate immune activation—making it an essential tool for both in vitro and in vivo research workflows.
-
EGCG: Mechanistic Innovations and Translational Barriers in
2026-07-21
Explore the multifaceted roles of (-)-Epigallocatechin gallate (EGCG) in apoptosis, antiangiogenesis, and antimicrobial research. This in-depth article uncovers EGCG's mechanistic challenges and translational hurdles, providing new insights beyond standard workflows.
-
VE-822 ATR Inhibitor: Precision Tools for DNA Damage Respons
2026-07-20
VE-822, a potent ATR inhibitor from APExBIO, empowers researchers to dissect DNA damage response and drive radiosensitization in challenging models like pancreatic ductal adenocarcinoma. This guide delivers practical workflows, troubleshooting insights, and actionable protocol parameters for integrating VE-822 into state-of-the-art cancer research and iPSC-based platforms.
-
Adefovir (GS-0393): Advanced Insights into Antiviral Mechani
2026-07-20
Explore the molecular antiviral mechanism of Adefovir (GS-0393) and its unique role in hepatitis B virus research. This article offers a deeper scientific analysis and highlights critical safety findings that influence experimental design.
-
Lamotrigine in Epilepsy & Cardiac Research: Applied Workflow
2026-07-19
Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) stands out for precise sodium channel and serotonin pathway modulation in epilepsy and cardiac studies. This guide details optimized protocols, troubleshooting strategies, and unique assay opportunities enabled by APExBIO's high-purity Lamotrigine.
-
Nitrocefin in Precision β-Lactamase Inhibitor Discovery
2026-07-18
Explore how Nitrocefin, a chromogenic cephalosporin substrate, is transforming β-lactamase enzymatic activity measurement and accelerating the rational discovery of novel inhibitors. This article delivers advanced insights into assay optimization and the latest in silico screening breakthroughs.
-
Bradford Protein Assay Kit: Technical Guide for Accurate Pro
2026-07-17
The Bradford Protein Assay Kit (SKU K4103) delivers rapid and sensitive protein concentration measurement for research workflows. It is optimal for samples without interfering substances such as detergents. For accurate results, avoid use in applications where interfering chemicals may impact dye binding.
-
Camptothecin (SKU A2877): Reliable DNA Damage Inducer for La
2026-07-17
This article provides evidence-based guidance for biomedical researchers on leveraging Camptothecin (SKU A2877) as a robust topoisomerase I inhibitor in cell-based assays. Scenario-driven Q&As address experimental design, optimization, data interpretation, and product selection, highlighting why APExBIO’s Camptothecin is a preferred choice for reproducible DNA damage and autophagy studies.
-
Mithramycin A: Integrative Insights for Cancer and Gene Regu
2026-07-16
Discover how Mithramycin A, an anticancer antibiotic, enables advanced study of transcriptional regulation and c-myc inhibition in cancer biology. This article uncovers unique assay implications and bridges mechanistic understanding with practical research design.